GSK boosted by specialty drugs, end to Zantac fallout

A British pharmaceutical group GSK reported Wednesday a sharp rise in annual net profit, boosted by strong sales of HIV, respiratory and cancer treatments as…

posteditor
posteditor
Articles: 27298